期刊文献+

肥厚型心肌病样心肌病五例及其分析 被引量:6

The clinical characteristics of 5 patients with inherited hypertrophic cardiomyopathy
原文传递
导出
摘要 目的探讨以左心室心肌肥厚为重要表型的非肥厚型心肌病的其他遗传性心肌病诊断线索。方法分析临床中5例因不可解释左心室心肌肥厚初诊肥厚型心肌病而后确诊为其他遗传性心肌病患者的临床特征、生化指标、心电图和确诊方法。结果5例患者心电图均示左心室高电压,ST-T改变。1例年轻男性伴肌无力、心室预激、丙氨酸转氨酶(ALT)、肌酸激酶(CK)持续升高,肌肉病理活检示肌纤维内含自噬和糖原空泡,诊断Danon’s病。1例年轻男性,短P—R间期,肌肉活检可见破碎红纤维,诊断线粒体心肌病。3例有发作性手足痛、皮肤血管角质瘤,血白细胞α-半乳糖苷酶活性降低,诊断Fabry病。结论因左心室心肌肥厚表现为肥厚型心肌病样的遗传性心肌病患者少见,通过仔细询问病史、临床表现特点和相关特殊检查可能明确诊断。 Objective To explore the clinical characteristics of patients with inherited hypertrophic cardiomyopathy. Methods The clinical characteristics, electrocardiogram, serum chemistry and diagnostic methods were retrospectively investigated in 5 patients with inherited hypertrophic cardiomyopathy. Results The electrocardiograms of all patients were abnormal, with prominent left ventricular voltage and ST-T changes. One male patient with elinicopathological features of early onset, muscle weakness, ventricular preexeitation, elevations of two serum proteins and intracytoplasmic vacuoles containing autophagic material and glycogen in biceps brachill muscle cells was diagnosed Danon's disease. Mitochondrial eardiomyopathy was diagnosed in one male patient with early onset, short PR interval and biopsy findings of ragged-red fibers in biceps brachill muscle. Three patients were diagnosed as Fabry's disease with clinical characteristics including pain and acroparesthesias, angiokeratoma and decrease of ~x-galactosidaseA activity. Conclusion Some of the rare inherited hypertrophic cardiomyopathy might easily be clinically misdiagnosed as hypertrophic cardiomyopathy, systemic and careful case history inquiring and specific relevant examinations would help to make the fight diagnosis in these patients.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2009年第4期320-323,共4页 Chinese Journal of Cardiology
关键词 心肌疾病 诊断 鉴别 Cardiomyopathies Diagnosis,differential
  • 相关文献

参考文献10

  • 1朱峰,廖玉华.关注左心室心肌肥厚的病因诊断[J].临床心血管病杂志,2008,24(1):1-2. 被引量:7
  • 2Danon MJ, Oh SJ, DiMauro S, et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology, 1981, 31:51-57.
  • 3Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature, 2000, 406:906-910.
  • 4Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology, 2002, 58 : 1773-1778.
  • 5Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med, 2005, 352:362-372.
  • 6Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J, 2000, 139 (2Pt3) :70-85.
  • 7Taylor GP. Neonatal mitochondrial cardiomyopathy. Pediatr Dev Pathol, 2004, 7:620-624.
  • 8Holmgren D, Wahlander H, Eriksson BO, et al. Cardiomyopathy in children with mitochondrial disease ; clinical course and cardiological findings. Eur Heart J, 2003, 24:280-288.
  • 9Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics, 2004, 114:925-931.
  • 10Clarke JT. Narrative review: fabry disease. Ann Intern Med, 2007, 146:425-433.

二级参考文献10

  • 1心肌病诊断与治疗建议[J].中华心血管病杂志,2007,35(1):5-16. 被引量:550
  • 2MARON B J, TOWBIN J A, THIENE G, et al. Contemporary definitions and classification of the cardiomyopathies: an american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention[J]. Circulation, 2006,113: 1807-1816.
  • 3DIMAURO S, SCHON E A. Mitochondial respiratory-chain diseases[J]. N Engl J Med, 2003,348:2656-2668.
  • 4HOPWOOD J J, BUNGE S, MORRIS C P, et al. Molecular basis of mucopolysaccharidosis type II: mutations in the iduronate-2-sulphatase gene[J]l. Hum Mutat, 1993, 2:435-442.
  • 5SCOTT H S, BUNGE S, GAL A, et al. Molecular genetics of mucopolysaccharidosis type I: diagnostic, clinical, and biological implications [J]. Hum Mutat, 1995,6:288-302.
  • 6FUKUDA T, ROBERTS A, PLOTZ P H, et al. Acid alpha-glucosidase deficiency ( Pompedisease ) [J]. Curr Neurol Neurosci Rep, 2007,7:71-77.
  • 7BUXBAUM J. The genetics of the amyldidoses: interactions with immunity and inflammatio[J]. Genes Immun, 2006,7:439-449.
  • 8ALPER G, NARAYANAN V. Friedreich's ataxia [J]. Pediatr Neurol, 2003, 28:335-341.
  • 9DEMERS C, ROULEAU J L, LEUNG T K, et al. Hypercalcemic cardiomyopathy associated with primary hyperparathyroidism mimicking primary obstructive hypertrophic cardiomyopathy [J]. Can J Cardiol, 1998,14 : 1397-1400.
  • 10TURSKA-KMIEC A, JANKOWSKA I,PAWLOWS-KA J, et al. Reversal of tacrolimus-related hypertrophic cardiomyopathy after conversion to rapamycin in a pediatric liver transplant recipient[J].Pediatr Transplant, 2007,11 : 319- 323.

共引文献6

同被引文献67

  • 1陈良华,刘伟,刘同宝,宋尚民,唐元升,朱兴雷.心尖肥厚型心肌病53例临床分析[J].临床心血管病杂志,2006,22(10):607-609. 被引量:7
  • 2陈国伟 郑宗锷.现代心脏内科学[M].长沙:湖南科学技术出版社,1999.624-625.
  • 3Arola LC, Jokinen E, Ruuskanen O, et al. Epidemiology ot idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol, 1997, 146: 385- 393.
  • 4Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med, 2003, 348: 1639-1647.
  • 5Lipshultz SE, Sleeper L, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two region of the United States. N Engl J Med, 2003, 348 : 1647-1655.
  • 6Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 2006, 296 : 1867-1876.
  • 7Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Circulation, 2007, 115:773-781.
  • 8Cox GF, Sleeper LA, Lowe AM, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics, 2006, 118 : 1519-1531.
  • 9Wilkinson JD, Sleeper LA, Alvarez JA, et al. The Pediatric Cardiomyopathy Registry : 1995-2007. Prog Pediatr Cardiol, 2008, 25.- 31-36.
  • 10Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail, 2009, 15: 83-97.

引证文献6

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部